Work

EP07.05-03 Neoadjuvant Chemotherapy or Chemo-IO in Resectable KRAS-Mutated Non-small Cell Lung Cancer (NSCLC) Patients: Single Center Experience

Year: 2023

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.1046

Authors: K. Wang, F.R. Rojas Alvarez, C.H. Leung, H. Kemp, W.E. Lewis, C.A. Arrechedera, L.M. Solis Soto, G. Blumenschein, B. Sepesi, F. Skoulidis, J.V. Heymach, D.L. Gibbons, J. Zhang, I.I. Wistuba, J.J. Lee, A. Weissferdt, S.G. Swisher, A. Pataer, T. Cascone, M.V. Negrao

Institutions: The University of Texas MD Anderson Cancer Center, Jazz Pharmaceuticals (United States)

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388044984

Cites:

Cited by: 1

Related to: 10